Biomaterials Forum Issues

This issue includes a highlight of the celebration of the 50-year legacy of the Society at the 2025 Annual Meeting, as well as details of the recent US FDA approval of two new medical therapies, and the US DOJ's efforts to block UnitedHealth Group's proposed acquisition of Amedisys. Read more inside!